Cargando…
The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies
Antiphospholipid syndrome (APS) is an autoimmune disease mainly characterised by vascular thrombosis and pregnancy morbidity. APS has broad spectrum of clinical manifestations. The digestive system involvement of antiphospholipid syndrome is a critical but under-recognised condition. Digestive syste...
Autores principales: | Zhang, Jin, Li, Cheng, Han, Xiaorong, Chen, Zhongbo, Adhikari, Binay Kumar, Wang, Yinghui, Wang, Yonggang, Sun, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381908/ https://www.ncbi.nlm.nih.gov/pubmed/34409894 http://dx.doi.org/10.1080/07853890.2021.1962964 |
Ejemplares similares
-
In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report
por: Pervez, Hira, et al.
Publicado: (2019) -
Clinical characteristics of infective endocarditis in patients with antineutrophil cytoplasmic antibody or antiphospholipid antibody: a retrospective study in Shanghai
por: Zhou, Zhuochao, et al.
Publicado: (2020) -
Relationship between osteonecrosis and antiphospholipid antibodies in patients with systemic lupus erythematosus: a systematic review protocol
por: Wei, Qijiao, et al.
Publicado: (2021) -
Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016) -
COVID-19 and the cardiovascular system: a study of pathophysiology and interpopulation variability
por: Zhao, Yifan, et al.
Publicado: (2023)